Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Cambrex op income doubles on increased API sales

14-Feb-2011 - Cambrex’ operating income more than doubled in the fourth quarter as a result of an upturn in API sales and lower production costs.

Live blog of news & views from Informex 2011 – replay

10-Feb-2011 - in-PharmaTechnologist presents a replay of our live blog covering all the news, views and multimedia from Informex 2011.

Minnesota “has raised its game” in pharma manufacturing

10-Feb-2011 - Minnesota “has raised its game” in pharma manufacturing and this revival, coupled to drug-device convergence, may justify continuing investment.

Bill to tackle prescription drug shortages enters US Senate

09-Feb-2011 - A bill requiring biopharm manufacturers to give the FDA early notification of potential drug shortages has been introduced to the US Senate.

Lotus expands new HQ to house employees

07-Feb-2011 - Lotus Pharmaceuticals’ new HQ in Beijing, China will be even bigger after the firm announces plans for employee apartments.

SPL responds to US FDA warning letter

07-Feb-2011 - US Heparin maker Scientific Protein Laboratories (SPL) says it has resolved “many of the issues” addressed in the US Food and Drug Administration (FDA) warning letter it received late last month.

News in brief

Uganda’s QCI to invest $80m in AIDS and anti-malarial drug capacity

03-Feb-2011 - Ugandan drugmaker Quality Chemicals Industries (QCI) will invest $80m in manufacturing operations to boost capacity for the production of generic AIDS and malaria drugs.

Cali bioproduction set to grow but education must improve

03-Feb-2011 - Californian bioproduction expansions could create jobs in 2011 but changes to education are needed to sustain growth, according to a survey.

Genzyme to sell intermediates biz to ICIG

02-Feb-2011 - Genzyme will sell its pharmaceutical intermediates business to International Chemical Investors Group (ICIG).

Solid-state training to advance China beyond API infancy

31-Jan-2011 - Crystal Pharmatech is to provide solid-state characterisation training in China to advance local API and drug development beyond its “infancy phase”.

Tianyin completes new Jiangchuan macrolide facility

31-Jan-2011 - Tianyin Pharmaceutical has completed the construction of its Jiangchuan macrolide facility (JCM) near Chengdu, China.

Abbott to cut 1,900 commercial & manufacturing jobs in US

27-Jan-2011 - Abbott Laboratories is to cut 1,900 US commercial and manufacturing jobs in response to healthcare reform and tough regulators.

Weak anti-counterfeiting slowing ASEAN harmonisation

26-Jan-2011 - Failure to reduce counterfeiting is one of a number of issues slowing healthcare regulation harmonisation in ASEAN.

Hospira kills production of death-row drug, Pentothal

25-Jan-2011 - Hospira has confirmed it will no longer make Pentothal - an anaesthetic used in lethal injections – as the company “never condoned” its use in executions.

Torrent investing in capacity to support international expansion

25-Jan-2011 - Torrent Pharma has begun construction of $75m API and formulation facilities in India to support its international expansion programme.

Dramatic lack of planning harming pandemic preparation

25-Jan-2011 - There is a dramatic lack of planning for the production and distribution of medical pandemic countermeasures, according to an OECD report.

FDA wants limits on bead size in “sprinkle delivery” drugs

24-Jan-2011 - The US FDA has suggested pharmaceutical firms use a maximum bead size of 2.0mm for modified-release drugs formulated for “sprinkle” delivery to avoid problems resulting from inadvertent chewing.

Amrutanjan & Austin form clinical trial material venture

24-Jan-2011 - Amrutanjan and Austin Chemical are establishing a joint venture to market Indian-produced clinical trial materials.

Teva to axe 200 Irvine jobs as all production halts

20-Jan-2011 - Teva has confirmed it will cut 200 jobs this year after a voluntary hold was placed on all manufacturing at its Irvine, California, US facility.

Euticals to buy Archimica to expand manufacturing base

18-Jan-2011 - Italy-based API maker Euticals will buy fine chemicals firm Archimica from investment group TowerBrook Capital Partners.

B-MS recalls 64m Puerto Rico-made Avalide tablets

17-Jan-2011 - Bristol-Myers Squibb has recalled 64m tablets of its Avalide blood pressure drug in the US and Puerto Rico over fears it has the potential for reduced efficacy.

Aurobindo to sell Chinese ingredient unit to Sinopharm

11-Jan-2011 - Aurobindo Pharma is to sell its Chinese unit to Sinopharm as part of a strategic shift from low-margin ingredients to more profitable formulations.

Legislation & resources needed as Croatia prepares to join EU

10-Jan-2011 - Legislation and resources are needed to support Croatian pharmaceutical regulators in preparation for accession to the European Union (EU).

FDA cGMP warning letters round up

06-Jan-2011 - in-PharmaTechnologist.com presents a round up of cGMP related warning letters published recently by the FDA.

Non-EU APIs a concern says EMA in 2015 Roadmap

05-Jan-2011 - The European Medicines Agency (EMA) has highlighted the quality APIs manufactured outside the EU as an area of concern in the draft 2015 road map it unveiled this week.

Sign up for your free newsletter